Clinical trial
Pregnenolone in the Management of Schizophrenia Patients
NCT00174889 · Sha'ar Menashe Mental Health Center, Other · Completed
Key facts
| NCT number | NCT00174889 |
|---|---|
| Title | Pregnenolone in the Management of Schizophrenia Patients |
| Official title | Efficacy and Safety of Pregnenolone Augmentation in the Management of Schizophrenia Patients: a Randomised Double-Blind Placebo-Controlled Trial |
| Lead sponsor | Sha'ar Menashe Mental Health Center, Other |
| Collaborators | Beersheva Mental Health Center |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Schizophrenia |
| Intervention type | Drug |
| Interventions | Pregnenolone |
| Enrollment | 60 |
| Start date | Jan 1, 2005 |
| Completion | May 1, 2007 |
| First posted | Sep 15, 2005 |
| Last update posted | May 21, 2008 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: